Glucotrack, Inc. (GCTK) Proxy Update

Glucotrack announced the reconvening of its Special Meeting of Shareholders on November 7, 2025.

The primary driver for this vote is compliance with NASDAQ Rule 5635(d) regarding a material issuance:

• Transaction: $20 million Equity Purchase Agreement with Sixth Borough Capital Fund LP.
• Impact: Approval allows the issuance of more than 20% of the Company’s outstanding Common Stock.
• Board Stance: The Board unanimously recommends shareholders vote “FOR” all proposals immediately.

Company Context: GCTK focuses on